M ATASSI to Humans
This is a "connection" page, showing publications M ATASSI has written about Humans.
Connection Strength
0.536
-
A proof-of-principle bite force study using two experimental test denture adhesives and a currently marketed denture adhesive. Clin Exp Dent Res. 2020 04; 6(2):266-273.
Score: 0.017
-
Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis. Appl Microbiol Biotechnol. 2017 Nov; 101(22):8165-8179.
Score: 0.015
-
The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule. Immunol Invest. 2018 Jan; 47(1):18-39.
Score: 0.015
-
Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule. Immunol Lett. 2017 10; 190:257-264.
Score: 0.015
-
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules. J Neuroimmunol. 2017 05 15; 306:31-39.
Score: 0.014
-
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. J Neuroimmunol. 2016 11 15; 300:36-46.
Score: 0.014
-
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 2016 Apr; 221(4):568-76.
Score: 0.013
-
Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions. Toxicon. 2015 Dec 01; 107(Pt A):50-8.
Score: 0.013
-
MHC Genes Linked to Autoimmune Disease. Crit Rev Immunol. 2015; 35(3):203-51.
Score: 0.012
-
Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other. Protein J. 2014 Jun; 33(3):278-88.
Score: 0.012
-
Reduction of established antibody responses against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol peptide conjugates. J Neuroimmunol. 2014 Jul 15; 272(1-2):29-34.
Score: 0.012
-
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. J Neuroimmunol. 2011 Dec 15; 240-241:121-8.
Score: 0.010
-
T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. Autoimmunity. 2012 Mar; 45(2):153-60.
Score: 0.010
-
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27.
Score: 0.010
-
Does Clostridium botulinum neurotoxin A exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons? Endocrine. 2011 Aug; 40(1):140-1; author reply 142-3.
Score: 0.010
-
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients. J Neuroimmunol. 2011 Aug 15; 237(1-2):66-72.
Score: 0.010
-
Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates. Immunol Lett. 2011 Jun 30; 137(1-2):46-52.
Score: 0.009
-
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92.
Score: 0.009
-
Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet. 2011 Feb; 38(1):55-62.
Score: 0.009
-
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2011 May; 44(3):167-76.
Score: 0.009
-
Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition. Crit Rev Immunol. 2010; 30(2):167-87.
Score: 0.009
-
Immune recognition of BoNTs A and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action. Toxicon. 2009 Oct; 54(5):600-13.
Score: 0.008
-
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008 Sep 23; 71(13):1040; author reply 1040-1.
Score: 0.008
-
The binding sites on botulinum neurotoxin B for synaptotagmin and for blocking antibodies. Biochem Biophys Res Commun. 2008 Nov 21; 376(3):631-2.
Score: 0.008
-
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment. Mol Immunol. 2008 Sep; 45(15):3878-88.
Score: 0.008
-
Molecular mechanisms of autoimmunity. Autoimmunity. 2008 Mar; 41(2):123-32.
Score: 0.008
-
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin. Mol Immunol. 2008 Feb; 45(4):910-24.
Score: 0.007
-
A peptide-based immunoassay for antibodies against botulinum neurotoxin A. J Mol Recognit. 2007 Jan-Feb; 20(1):15-21.
Score: 0.007
-
Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action. Crit Rev Immunol. 2007; 27(4):319-41.
Score: 0.007
-
Preface: Immunology of protein and peptide therapies. Crit Rev Immunol. 2007; 27(3):vii-viii.
Score: 0.007
-
Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease. Crit Rev Immunol. 2007; 27(3):271-88.
Score: 0.007
-
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology. 2006 Dec 26; 67(12):2233-5.
Score: 0.007
-
On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology (Reading). 2006 Jul; 152(Pt 7):1891-1895.
Score: 0.007
-
Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006 Jun; 39(4):277-88.
Score: 0.007
-
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol Immunol. 2007 Feb; 44(5):1029-41.
Score: 0.007
-
Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies. J Neurosci Methods. 2006 Mar 15; 151(2):90-6.
Score: 0.007
-
Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. J Neuroimmunol. 2006 Feb; 171(1-2):8-16.
Score: 0.007
-
Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients. Autoimmunity. 2005 Mar; 38(2):161-9.
Score: 0.006
-
Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity. Hum Immunol. 2005 Jan; 66(1):32-42.
Score: 0.006
-
Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin. Protein J. 2005 Jan; 24(1):37-49.
Score: 0.006
-
Basic immunological aspects of botulinum toxin therapy. Mov Disord. 2004 Mar; 19 Suppl 8:S68-84.
Score: 0.006
-
Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A. Protein J. 2004 Jan; 23(1):39-52.
Score: 0.006
-
Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest. 2002 Aug-Nov; 31(3-4):247-62.
Score: 0.005
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Crit Rev Immunol. 2001; 21(1-3):1-27.
Score: 0.005
-
Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of Myasthenia gravis? Hum Immunol. 2000 Mar; 61(3):255-65.
Score: 0.004
-
Subunit interacting surfaces of human hemoglobin in solution: localization of the alpha-beta subunit interacting surfaces on the alpha-chain by a comprehensive synthetic strategy. J Protein Chem. 1999 Feb; 18(2):179-85.
Score: 0.004
-
Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins. Crit Rev Immunol. 1999; 19(3):219-60.
Score: 0.004
-
In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies. Br J Cancer. 1998 Dec; 78(12):1578-85.
Score: 0.004
-
Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity. Anticancer Res. 1998 Mar-Apr; 18(2B):1333-40.
Score: 0.004
-
Anti-urokinase-type plasminogen activator monoclonal antibodies inhibit the proliferation of human breast cancer cell lines in vitro. Tumour Biol. 1998; 19(4):229-37.
Score: 0.004
-
In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines. Jpn J Cancer Res. 1997 Nov; 88(11):1094-9.
Score: 0.004
-
Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Crit Rev Immunol. 1997; 17(5-6):481-95.
Score: 0.004
-
Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species. J Protein Chem. 1996 Oct; 15(7):691-700.
Score: 0.003
-
Autoimmune recognition of acetylcholine receptor and manipulation of the autoimmune responses by synthetic peptides. Adv Exp Med Biol. 1995; 383:141-56.
Score: 0.003
-
Mapping of the polypeptide chain organization of the main extracellular domain of the alpha-subunit in membrane-bound acetylcholine receptor by antipeptide antibodies spanning the entire domain. Adv Exp Med Biol. 1994; 347:221-8.
Score: 0.003
-
Molecular recognition of acetylcholine receptor. Recognition by alpha-neurotoxins and by immune and autoimmune responses and manipulation of the responses. Adv Neuroimmunol. 1994; 4(4):403-32.
Score: 0.003
-
Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance. Adv Exp Med Biol. 1994; 347:65-75.
Score: 0.003
-
Biological activities of rat antisera raised against synthetic peptides of human thyrotropin receptor. Endocr J. 1993 Oct; 40(5):607-12.
Score: 0.003
-
Amino acid substitutions outside a preselected antigenic region in hemoglobin affect the binding to monoclonal antibodies obtained by immunization with the synthetic region. J Protein Chem. 1993 Aug; 12(4):403-12.
Score: 0.003
-
Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease. Mol Cell Endocrinol. 1993 Mar; 92(1):77-82.
Score: 0.003
-
Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
Score: 0.003
-
HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells. Hum Immunol. 1992 May; 34(1):31-8.
Score: 0.003
-
Biological activities of rabbit antibodies against synthetic human thyrotropin receptor peptides representing thyrotropin binding regions. Biochem Biophys Res Commun. 1992 Feb 14; 182(3):1369-75.
Score: 0.003
-
Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor. Proc Natl Acad Sci U S A. 1991 May 01; 88(9):3613-7.
Score: 0.002
-
The short-neurotoxin-binding regions on the alpha-chain of human and Torpedo californica acetylcholine receptors. Biochem J. 1991 Mar 15; 274 ( Pt 3):849-54.
Score: 0.002
-
Autoimmune recognition profile of the alpha chain of human acetylcholine receptor in myasthenia gravis. Adv Exp Med Biol. 1991; 303:255-61.
Score: 0.002
-
Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence. Adv Exp Med Biol. 1991; 303:263-70.
Score: 0.002
-
Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s). Adv Exp Med Biol. 1991; 303:271-83.
Score: 0.002
-
Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem. 1990 Dec; 9(6):735-42.
Score: 0.002
-
Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit. Eur J Immunol. 1990 Dec; 20(12):2563-9.
Score: 0.002
-
Acetylcholine receptor-alpha-bungarotoxin interactions: determination of the region-to-region contacts by peptide-peptide interactions and molecular modeling of the receptor cavity. Proc Natl Acad Sci U S A. 1990 Aug; 87(16):6156-60.
Score: 0.002
-
HLA-DR peptide inhibits HIV-induced syncytia. Immunol Lett. 1990 May; 24(2):127-31.
Score: 0.002
-
Mapping of the full profile of T cell allorecognition regions on HLA-DR2 beta subunit. Eur J Immunol. 1990 Apr; 20(4):713-21.
Score: 0.002
-
Localization and synthesis of an insulin-binding region on human insulin receptor. J Protein Chem. 1990 Apr; 9(2):229-33.
Score: 0.002
-
DR beta peptides block the antigen-specific response but not the alloresponse of a dual-reactive T-cell clone. Immunol Lett. 1990 Mar-Apr; 24(1):43-7.
Score: 0.002
-
Generation of species-specific antihemoglobin antibodies by immunization with synthetic peptides of human hemoglobin. J Protein Chem. 1989 Dec; 8(6):767-78.
Score: 0.002
-
Recognition sites of hemoglobin and the preparation of antibodies with preselected specificity for clinical diagnosis and forensic medicine. Nihon Hoigaku Zasshi. 1988 Dec; 42(6):469-75.
Score: 0.002
-
Molecular recognition of human insulin receptor by autoantibodies in a human serum. Immunol Invest. 1988 May; 17(3):237-42.
Score: 0.002
-
The regions of alpha-neurotoxin binding on the extracellular part of the alpha-subunit of human acetylcholine receptor. J Protein Chem. 1988 Apr; 7(2):173-7.
Score: 0.002
-
Antigenic regions on the beta chain of human chorionic gonadotropin and development of hormone specific antibodies. Immunol Invest. 1987 Nov; 16(7):607-18.
Score: 0.002
-
The continuous antigenic regions in the second domain of the beta chain of human MHC DR2 antigen: antigenic profile of the entire extracellular part of the chain. Eur J Immunol. 1987 Jun; 17(6):769-73.
Score: 0.002
-
Immune recognition of human major histocompatibility antigens: localization by a comprehensive synthetic strategy of the continuous antigenic sites in the first domain of HLA-DR2 beta chain. Eur J Immunol. 1987 Apr; 17(4):497-502.
Score: 0.002
-
T-cell recognition and antigen presentation of myoglobin. Adv Exp Med Biol. 1987; 225:65-87.
Score: 0.002
-
Human haptoglobin binds to human myoglobin. Biochim Biophys Acta. 1986 Sep 26; 873(2):312-5.
Score: 0.002
-
Antibody recognition of ragweed allergen Ra3: localization of the full profile of the continuous antigenic sites by synthetic overlapping peptides representing the entire protein chain. Eur J Immunol. 1986 Mar; 16(3):229-35.
Score: 0.002
-
Antigenic structure of human haemoglobin. Localization of the antigenic sites of the beta-chain in three host species by synthetic overlapping peptides representing the entire chain. Biochem J. 1986 Mar 01; 234(2):441-7.
Score: 0.002
-
Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding sites on the beta-chain of human haemoglobin by synthetic overlapping peptides encompassing the entire chain. Biochem J. 1986 Mar 01; 234(2):453-6.
Score: 0.002
-
Subunit interacting surfaces of human haemoglobin. Localization of the alpha-subunit-beta-subunit interacting surfaces on the beta-chain by a comprehensive synthetic strategy. Biochem J. 1986 Mar 01; 234(2):457-61.
Score: 0.002
-
Localization of the continuous allergenic sites of ragweed allergen Ra3 by a comprehensive synthetic strategy. FEBS Lett. 1985 Aug 19; 188(1):96-100.
Score: 0.002
-
Discovery and implications of the immunogenicity of free small synthetic peptides: powerful tools for manipulating the immune system and for production of antibodies and T cells of preselected submolecular specificities. Crit Rev Immunol. 1985; 5(4):387-409.
Score: 0.002
-
Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking of protein binding sites. Eur J Biochem. 1984 Nov 15; 145(1):1-20.
Score: 0.002
-
Immune recognition of serum albumin. XVI. Role of adjuvant in the autoimmune response to mouse serum albumin. Mol Immunol. 1982 Nov; 19(11):1509-12.
Score: 0.001
-
Structurally inherent antigenic sites. Localization of the antigenic sites of the alpha-chain of human haemoglobin in three host species by a comprehensive synthetic approach. Biochem J. 1982 Apr 01; 203(1):201-8.
Score: 0.001
-
Immune recognition of serum albumin--XIII. Autoreactivity with rabbit serum albumin of rabbit antibodies against bovine or human serum albumins and autoimmune recognition of rabbit serum albumin. Mol Immunol. 1981 Nov; 18(11):961-7.
Score: 0.001
-
Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding site on the alpha-chain of human haemoglobin. Biochem J. 1981 Aug 01; 197(2):507-10.
Score: 0.001
-
A novel and comprehensive synthetic approach for the elucidation of protein antigenic structures. Determination of the full antigenic profile of the alpha-chain of human haemoglobin. Biochem J. 1980 Oct 01; 191(1):261-4.
Score: 0.001
-
Immunochemistry of serum albumin. X. Five major antigenic sites of human serum albumin are extrapolated from bovine albumin and confirmed by synthetic peptides. Mol Immunol. 1980 Jan; 17(1):139-42.
Score: 0.001
-
Haemoglobin binding with haptoglobin. Unequivocal demonstration that the beta-chains of human haemoglobin bind to haptoglobin. Biochem J. 1980 Jan 01; 185(1):285-7.
Score: 0.001
-
Structure and activity of ragweed antigen E. II. Allergenic crossreactivity of the subunits. J Allergy Clin Immunol. 1979 Dec; 64(6 Pt 1):539-45.
Score: 0.001
-
Prediction and conformation by synthesis of two antigenic sites in human haemoglobin by extrapolation from the known antigenic structure of sperm-whale myoglobin. Biochem J. 1977 Oct 01; 167(1):275-8.
Score: 0.001
-
Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve. 1993 Dec; 16(12):1293-301.
Score: 0.001
-
Immunochemistry of sperm-whale myoglobin. Conformation and immunochemistry of derivatives prepared by reaction with diazonium-1H-tetrazole. Evaluation of the specificity of the reagent. Biochemistry. 1973 Feb 27; 12(5):942-7.
Score: 0.001
-
Binding of thyroid hormones to human hemoglobin and localization of the binding site. J Protein Chem. 1990 Dec; 9(6):743-50.
Score: 0.001
-
Specific reduction of carboxyl groups in peptides and proteins by diborane. Biochem J. 1969 Feb; 111(4):593-601.
Score: 0.001
-
Significance of the amino acid composition of proteins. 1. Composition of hemoglobins and myoglobins in relation to their structure, function and evolution. J Theor Biol. 1966 Jul; 11(2):227-41.
Score: 0.000
-
Infra-red spectral analysis of the apoproteins of some haemoglobins and myoglobins. Nature. 1966 Mar 19; 209(5029):1211-3.
Score: 0.000
-
Immunochemical studies of hemoglobin and the role of the sulfhydryl groups. Immunochemistry. 1965 Dec; 2(4):379-89.
Score: 0.000
-
Neuraminic acid and its relation to chronic bronchitis. V. Glass column electrophoresis of sputum. Clin Chim Acta. 1962 Sep; 7:706-9.
Score: 0.000
-
Genetic control of the immune response to haemoglobin. IV. Ly-1+ T-cells and appropriate non-H-2 genes are required for in vitro responses to alpha- and beta-subunits of human adult haemoglobin. J Immunogenet. 1982 Apr; 9(2):93-100.
Score: 0.000
-
Genetic control of the immune response to hemoglobin and its subunits. Adv Exp Med Biol. 1982; 150:127-40.
Score: 0.000
-
Genetic control of the immune response to haemoglobin. III. Variant A beta (bm12) but not Ae (D2.GD) Ia polypeptides alter immune responsiveness towards the alpha -subunit of human haemoglobin. J Immunogenet. 1981 Dec; 8(6):471-6.
Score: 0.000
-
Genetic control of the immune response to haemoglobin. II. Studies using purified alpha-chain and beta-chain as immunogens. J Immunogenet. 1981 Oct; 8(5):395-403.
Score: 0.000
-
Neuraminic acid and its relation to chronic bronchitis. III. Carbohydrate constituents of sputum. Clin Chim Acta. 1959 Nov; 4:823-7.
Score: 0.000